Table 1.

Effects of the Peptide Ac2-26 and the Fpr Antagonist Boc2 Treatment on Neutrophil Influx of Peritoneal Fluid

Neutrophils × 105/ml in peritoneal fluid
	WT	Anxa1-null	Fpr1-null
Control	0.00 ± 0.00	0.00 ± 0.00	0.03 ± 0.03
CG4h	14.33 ± 1.76**	30.67 ± 1.2***	16.33 ± 2.02**
Ac2-26 + CG4h	8.0 ± 0.57§	6.33 ± 2.18§§	9.0 ± 0.57§
Boc2 + Ac2-26 + CG4h	14.0 ± 1.15#

CG, Carrageenin. Data are mean ± SEM of n = 5 mice per group. 

^**P < 0.01 and 

^***P < 0.001 vs. respective vehicle group; 

^§P < 0.05 and 

^§§P < 0.01 vs. respective CG4h group; 

^#P < 0.05 vs. respective Ac2-26 + CG4h group. ANOVA plus Bonferroni test.